PharVision Advisers’s Gladstone Land Corp LAND Stock Holding History

PharVision Advisers’s Portfolio LAND Stock Details LAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,859	Closed	-$209K	–	395
2025 Q4	$209K	Buy	+22,859	New	+$209K	0.11%	519

Other funds holding LAND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PharVision Advisers's LAND Position: Q1 2026 in Review

PharVision Advisers sold out of Gladstone Land Corp (LAND) in Q1 2026, closing a stake of 22,859 shares — an estimated $209K sold.

PharVision Advisers first reported a position in LAND in Q4 2025 and held it in 1 quarter. The position peaked at $209K in Q4 2025. 173 funds tracked by Wall St. Rank hold LAND as of Q1 2026.

PharVision Advisers reported no remaining Gladstone Land Corp position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 22,859 Gladstone Land Corp shares in Q1 2026, an estimated $209K.
PharVision Advisers first reported a position in Gladstone Land Corp in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Gladstone Land Corp position peaked at $209K in Q4 2025.
173 funds tracked by Wall St. Rank held Gladstone Land Corp as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.